Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671]

Matthias Briel, Mirjam Christ-Crain, Jim Young, Philipp Schuetz, Peter Huber, Pierre Périat, Heiner C Bucher, Beat Müller, Matthias Briel, Mirjam Christ-Crain, Jim Young, Philipp Schuetz, Peter Huber, Pierre Périat, Heiner C Bucher, Beat Müller

Abstract

Background: Acute respiratory tract infections (ARTI) are among the most frequent reasons for consultations in primary care. Although predominantly viral in origin, ARTI often lead to the prescription of antibiotics for ambulatory patients, mainly because it is difficult to distinguish between viral and bacterial infections. Unnecessary antibiotic use, however, is associated with increased drug expenditure, side effects and antibiotic resistance. A novel approach is to guide antibiotic therapy by procalcitonin (ProCT), since serum levels of ProCT are elevated in bacterial infections but remain lower in viral infections and inflammatory diseases. The aim of this trial is to compare a ProCT-guided antibiotic therapy with a standard approach based on evidence-based guidelines for patients with ARTI in primary care.

Methods/design: This is a randomised controlled trial in primary care with an open intervention. Adult patients judged by their general practitioner (GP) to need antibiotics for ARTI are randomised in equal numbers either to standard antibiotic therapy or to ProCT-guided antibiotic therapy. Patients are followed-up after 1 week by their GP and after 2 and 4 weeks by phone interviews carried out by medical students blinded to the goal of the trial. Exclusion criteria for patients are antibiotic use in the previous 28 days, psychiatric disorders or inability to give written informed consent, not being fluent in German, severe immunosuppression, intravenous drug use, cystic fibrosis, active tuberculosis, or need for immediate hospitalisation. The primary endpoint is days with restrictions from ARTI within 14 days after randomisation. Secondary outcomes are antibiotic use in terms of antibiotic prescription rate and duration of antibiotic treatment in days, days off work and days with side-effects from medication within 14 days, and relapse rate from the infection within 28 days after randomisation.

Discussion: We aim to include 600 patients from 50 general practices in the Northwest of Switzerland. Data from the registry of the Swiss Medical Association suggests that our recruited GPs are representative of all eligible GPs with respect to age, proportion of female physicians, specialisation, years of postgraduate training and years in private practice.

Figures

Figure 1
Figure 1
Summary of the trial design.
Figure 2
Figure 2
Flow diagram of recruited general practitioners.

References

    1. Schappert SM. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997. Vital Health Stat 13. 1999. pp. i–39.
    1. Arroll B, Kenealy T. Antibiotics for the common cold and acute purulent rhinitis. The Cochrane Database of Systematic Reviews 2002, Issue 3 Art No :CD000247. 2002.
    1. Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat. The Cochrane Database of Sytematic Reviews 2004, Issue 2 Art No :CD000023. 2004.
    1. Williams JW, Aguilar C, Cornell J, Chiquette E Dolor RJ, Makela M, Holleman DR, Simel DL. Antibiotics for acute maxillary sinusitis. The Cochrane Database of Systematic Reviews 2002, Issue 3 Art No :CD000243. 2002.
    1. Smucny J, Fahey T, Becker L, Glazier R. Antibiotics for acute bronchitis. The Cochrane Database of Systematic Reviews 2004, Issue 4 Art No :CD000245. 2004.
    1. Glasziou PP, Del Mar CB, Sanders SL, Hayem M. Antibiotics for acute otitis media in children. The Cochrane Database of Systematic Reviews 2003, Issue 4 Art No :CD000219. 2003.
    1. Graham V, Lasserson TJ, Rowe BH. Antibiotics for acute asthma. The Cochrane Database of Systematic Reviews 2001, Issue 2 Art No :CD002741. 2001.
    1. Bjerre LM, Verheij TJM, Kochen MM. Antibiotics for community acquired pneumonia in adult outpatients. The Cochrane Database of Systematic Reviews 2004, Issue 2 Art No :CD002109. 2004.
    1. Griffin JJ, Meduri GU. New approaches in the diagnosis of nosocomial pneumonia. Med Clin North Am. 1994;78:1091–1122.
    1. Gonzales R, Corbett K. The culture of antibiotics. Am J Med. 1999;107:525–526. doi: 10.1016/S0002-9343(99)00302-2.
    1. Cunha BA. The antibiotic treatment of community-acquired, atypical, and nosocomial pneumonias. Med Clin North Am. 1995;79:581–597.
    1. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730–1754.
    1. Halm EA, Teirstein AS. Clinical practice. Management of community-acquired pneumonia. N Engl J Med. 2002;347:2039–2045. doi: 10.1056/NEJMcp020499.
    1. Mainous AGIII, Hueston WJ. The cost of antibiotics in treating upper respiratory tract infections in a medicaid population. Arch Fam Med. 1998;7:45–49. doi: 10.1001/archfami.7.1.45.
    1. Freeman J, Rosner BA, McGowan JEJ. Adverse effects of nosocomial infection. J Infect Dis. 1979;140:732–740.
    1. Schito GC, Debbia EA, Marchese A. The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project. J Antimicrob Chemother. 2000;46 Suppl T1:3–9.
    1. Wenzel RP. The antibiotic pipeline--challenges, costs, and values. N Engl J Med. 2004;351:523–526. doi: 10.1056/NEJMp048093.
    1. Guillemot D, Courvalin P. Better control of antibiotic resistance. Clin Infect Dis. 2001;33:542–547. doi: 10.1086/322583.
    1. Raz R, Porat V, Ephros M. Can an educational program improve the diagnosis and treatment of pharyngotonsillitis in the ambulatory care setting? Isr J Med Sci. 1995;31:432–435.
    1. Santoso B, Suryawati S, Prawaitasari JE. Small group intervention vs formal seminar for improving appropriate drug use. Soc Sci Med. 1996;42:1163–1168. doi: 10.1016/0277-9536(95)00390-8.
    1. Bexell A, Lwando E, von Hofsten B, Tembo S, Eriksson B, Diwan VK. Improving drug use through continuing education: a randomized controlled trial in Zambia. J Clin Epidemiol. 1996;49:355–357. doi: 10.1016/0895-4356(95)00059-3.
    1. De Santis G, Harvey KJ, Howard D, Mashford ML, Moulds RF. Improving the quality of antibiotic prescription patterns in general practice. The role of educational intervention. Med J Aust. 1994;160:502–505.
    1. Welschen I, Kuyvenhoven MM, Hoes AW, Verheij TJ. Effectiveness of a multiple intervention to reduce antibiotic prescribing for respiratory tract symptoms in primary care: randomised controlled trial. BMJ. 2004;329:431. doi: 10.1136/bmj.38182.591238.EB.
    1. Zwar N, Wolk J, Gordon J, Sanson-Fisher R, Kehoe L. Influencing antibiotic prescribing in general practice: a trial of prescriber feedback and management guidelines. Fam Pract. 1999;16:495–500. doi: 10.1093/fampra/16.5.495.
    1. Gonzales R, Steiner JF, Lum A, Barrett PHJ. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA. 1999;281:1512–1519. doi: 10.1001/jama.281.16.1512.
    1. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515–518. doi: 10.1016/0140-6736(93)90277-N.
    1. Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 2000;28:977–983. doi: 10.1097/00003246-200004000-00011.
    1. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164:396–402.
    1. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206–217. doi: 10.1086/421997.
    1. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Muller B. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004;363:600–607. doi: 10.1016/S0140-6736(04)15591-8.
    1. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Huber PR, Leuppi J, Mueller C, Tamm M, Muller B. Procalcitonin guidance significantly reduces antibiotic duration in community acquired pneumonia. Proc 25th Int Congress of Intensive and Emergency Medicine (ISICEM) 2005. p. P166.
    1. Scott JG, Cohen D, DiCicco-Bloom B, Orzano AJ, Jaen CR, Crabtree BF. Antibiotic use in acute respiratory infections and the ways patients pressure physicians for a prescription. J Fam Pract. 2001;50:853–858.
    1. Kumar S, Little P, Britten N. Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study. BMJ. 2003;326:138. doi: 10.1136/bmj.326.7381.138.
    1. Ruttimann S, Keck B, Hartmeier C, Maetzel A, Bucher HC. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis. 2004;38:348–356. doi: 10.1086/380964.
    1. Poses RM, Cebul RD, Wigton RS. You can lead a horse to water--improving physicians' knowledge of probabilities may not affect their decisions. Med Decis Making. 1995;15:65–75.
    1. Wensing M, Grol R. Single and combined strategies for implementing changes in primary care: a literature review. Int J Qual Health Care. 1994;6:115–132.
    1. Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JM, Hoffman JR, Sande MA. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med. 2001;134:479–486.
    1. Gonzales R, Bartlett JG, Besser RE, Hickner JM, Hoffman JR, Sande MA. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med. 2001;134:490–494.
    1. Hickner JM, Bartlett JG, Besser RE, Gonzales R, Hoffman JR, Sande MA. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med. 2001;134:498–505.
    1. Cooper RJ, Hoffman JR, Bartlett JG, Besser RE, Gonzales R, Hickner JM, Sande MA. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med. 2001;134:509–517.
    1. Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JM, Hoffman JR, Sande MA. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med. 2001;134:521–529.
    1. Snow V, Lascher S, Mottur-Pilson C. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2001;134:595–599.
    1. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med. 2001;134:657–662.
    1. Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods. BMJ. 1996;313:36–39.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit